List of Tables
Table 1. Global Pathological Examination Market Size Growth Rate (CAGR) by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Pathological Examination Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Pathological Examination Market Size by Region (US$ Million): 2024 VS 2031
Table 4. Global Pathological Examination Revenue by Region (2020-2025) & (US$ Million)
Table 5. Global Pathological Examination Revenue Forecast by Region (2026-2031) & (US$ Million)
Table 6. Global Pathological Examination Revenue by Type (2020-2025) & (US$ Million)
Table 7. Global Pathological Examination Revenue Forecast by Type (2026-2031) & (US$ Million)
Table 8. Global Pathological Examination Revenue by Application (2020-2025) & (US$ Million)
Table 9. Global Pathological Examination Revenue Forecast by Application (2026-2031) & (US$ Million)
Table 10. Pathological Examination Revenue by Company (2020-2025) & (US$ Million)
Table 11. Pathological Examination Revenue Share by Company (2020-2025)
Table 12. Ranking of Global Top Pathological Examination Players by Revenue (US$ Million) in 2024
Table 13. Global Pathological Examination Companies Market Concentration Ratio (CR5 and HHI) & (2020-2025)
Table 14. Global Pathological Examination by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pathological Examination as of 2024)
Table 15. Global Pathological Examination Companies Headquarters
Table 16. Date of International Companies Enter into Pathological Examination Market
Table 17. Global Pathological Examination Companies Product & Service
Table 18. Global Pathological Examination Mergers & Acquisitions, Expansion Plans
Table 19. Quest Diagnostics Corporation Information
Table 20. Quest Diagnostics Description and Business Overview
Table 21. Quest Diagnostics Pathological Examination Product
Table 22. Quest Diagnostics Pathological Examination Revenue (US$ Million) and Gross Margin (2020-2025)
Table 23. Quest Diagnostics Revenue Proportion of Pathological Examination by Product in 2024
Table 24. Quest Diagnostics Revenue Proportion of Pathological Examination by Application in 2024
Table 25. Quest Diagnostics Revenue Proportion of Pathological Examination by Geographic Area in 2024
Table 26. Quest Diagnostics Recent Developments
Table 27. Sonic Healthcare Corporation Information
Table 28. Sonic Healthcare Description and Business Overview
Table 29. Sonic Healthcare Pathological Examination Product
Table 30. Sonic Healthcare Pathological Examination Revenue (US$ Million) and Gross Margin (2020-2025)
Table 31. Sonic Healthcare Revenue Proportion of Pathological Examination by Product in 2024
Table 32. Sonic Healthcare Revenue Proportion of Pathological Examination by Application in 2024
Table 33. Sonic Healthcare Revenue Proportion of Pathological Examination by Geographic Area in 2024
Table 34. Sonic Healthcare Recent Developments
Table 35. Lab Corp Corporation Information
Table 36. Lab Corp Description and Business Overview
Table 37. Lab Corp Pathological Examination Product
Table 38. Lab Corp Pathological Examination Revenue (US$ Million) and Gross Margin (2020-2025)
Table 39. Lab Corp Revenue Proportion of Pathological Examination by Product in 2024
Table 40. Lab Corp Revenue Proportion of Pathological Examination by Application in 2024
Table 41. Lab Corp Revenue Proportion of Pathological Examination by Geographic Area in 2024
Table 42. Lab Corp Recent Developments
Table 43. Unilabs Corporation Information
Table 44. Unilabs Description and Business Overview
Table 45. Unilabs Pathological Examination Product
Table 46. Unilabs Pathological Examination Revenue (US$ Million) and Gross Margin (2020-2025)
Table 47. Unilabs Revenue Proportion of Pathological Examination by Product in 2024
Table 48. Unilabs Revenue Proportion of Pathological Examination by Application in 2024
Table 49. Unilabs Revenue Proportion of Pathological Examination by Geographic Area in 2024
Table 50. Unilabs Recent Developments
Table 51. SYNLAB International Corporation Information
Table 52. SYNLAB International Description and Business Overview
Table 53. SYNLAB International Pathological Examination Product
Table 54. SYNLAB International Pathological Examination Revenue (US$ Million) and Gross Margin (2020-2025)
Table 55. SYNLAB International Revenue Proportion of Pathological Examination by Product in 2024
Table 56. SYNLAB International Revenue Proportion of Pathological Examination by Application in 2024
Table 57. SYNLAB International Revenue Proportion of Pathological Examination by Geographic Area in 2024
Table 58. SYNLAB International Recent Developments
Table 59. BML Corporation Information
Table 60. BML Description and Business Overview
Table 61. BML Pathological Examination Product
Table 62. BML Pathological Examination Revenue (US$ Million) and Gross Margin (2020-2025)
Table 63. BML Revenue Proportion of Pathological Examination by Product in 2024
Table 64. BML Revenue Proportion of Pathological Examination by Application in 2024
Table 65. BML Revenue Proportion of Pathological Examination by Geographic Area in 2024
Table 66. BML Recent Developments
Table 67. Pathologists Diagnostic Corporation Information
Table 68. Pathologists Diagnostic Description and Business Overview
Table 69. Pathologists Diagnostic Pathological Examination Product
Table 70. Pathologists Diagnostic Pathological Examination Revenue (US$ Million) and Gross Margin (2020-2025)
Table 71. Pathologists Diagnostic Revenue Proportion of Pathological Examination by Product in 2024
Table 72. Pathologists Diagnostic Revenue Proportion of Pathological Examination by Application in 2024
Table 73. Pathologists Diagnostic Revenue Proportion of Pathological Examination by Geographic Area in 2024
Table 74. Pathologists Diagnostic Recent Developments
Table 75. StageBio Corporation Information
Table 76. StageBio Description and Business Overview
Table 77. StageBio Pathological Examination Product
Table 78. StageBio Pathological Examination Revenue (US$ Million) and Gross Margin (2020-2025)
Table 79. StageBio Revenue Proportion of Pathological Examination by Product in 2024
Table 80. StageBio Revenue Proportion of Pathological Examination by Application in 2024
Table 81. StageBio Revenue Proportion of Pathological Examination by Geographic Area in 2024
Table 82. StageBio Recent Developments
Table 83. KingMed Diagnostics Group Corporation Information
Table 84. KingMed Diagnostics Group Description and Business Overview
Table 85. KingMed Diagnostics Group Pathological Examination Product
Table 86. KingMed Diagnostics Group Pathological Examination Revenue (US$ Million) and Gross Margin (2020-2025)
Table 87. KingMed Diagnostics Group Revenue Proportion of Pathological Examination by Product in 2024
Table 88. KingMed Diagnostics Group Revenue Proportion of Pathological Examination by Application in 2024
Table 89. KingMed Diagnostics Group Revenue Proportion of Pathological Examination by Geographic Area in 2024
Table 90. KingMed Diagnostics Group Recent Developments
Table 91. Dian Diagnostics Group Corporation Information
Table 92. Dian Diagnostics Group Description and Business Overview
Table 93. Dian Diagnostics Group Pathological Examination Product
Table 94. Dian Diagnostics Group Pathological Examination Revenue (US$ Million) and Gross Margin (2020-2025)
Table 95. Dian Diagnostics Group Revenue Proportion of Pathological Examination by Product in 2024
Table 96. Dian Diagnostics Group Revenue Proportion of Pathological Examination by Application in 2024
Table 97. Dian Diagnostics Group Revenue Proportion of Pathological Examination by Geographic Area in 2024
Table 98. Dian Diagnostics Group Recent Developments
Table 99. Adicon Clinical Laboratories Inc. Corporation Information
Table 100. Adicon Clinical Laboratories Inc. Description and Business Overview
Table 101. Adicon Clinical Laboratories Inc. Pathological Examination Product
Table 102. Adicon Clinical Laboratories Inc. Pathological Examination Revenue (US$ Million) and Gross Margin (2020-2025)
Table 103. Adicon Clinical Laboratories Inc. Revenue Proportion of Pathological Examination by Product in 2024
Table 104. Adicon Clinical Laboratories Inc. Revenue Proportion of Pathological Examination by Application in 2024
Table 105. Adicon Clinical Laboratories Inc. Revenue Proportion of Pathological Examination by Geographic Area in 2024
Table 106. Adicon Clinical Laboratories Inc. Recent Developments
Table 107. Huayin Health Corporation Information
Table 108. Huayin Health Description and Business Overview
Table 109. Huayin Health Pathological Examination Product
Table 110. Huayin Health Pathological Examination Revenue (US$ Million) and Gross Margin (2020-2025)
Table 111. Huayin Health Revenue Proportion of Pathological Examination by Product in 2024
Table 112. Huayin Health Revenue Proportion of Pathological Examination by Application in 2024
Table 113. Huayin Health Revenue Proportion of Pathological Examination by Geographic Area in 2024
Table 114. Huayin Health Recent Developments
Table 115. North America Pathological Examination Revenue by Country (2020-2025) & (US$ Million)
Table 116. North America Pathological Examination Revenue by Country (2026-2031) & (US$ Million)
Table 117. North America Pathological Examination Revenue by Type (2020-2025) & (US$ Million)
Table 118. North America Pathological Examination Revenue by Application (2020-2025) & (US$ Million)
Table 119. Asia-Pacific Pathological Examination Revenue by Region (2020-2025) & (US$ Million)
Table 120. Asia-Pacific Pathological Examination Revenue by Region (2026-2031) & (US$ Million)
Table 121. Asia-Pacific Pathological Examination Revenue by Type (2020-2025) & (US$ Million)
Table 122. Asia-Pacific Pathological Examination Revenue by Application (2020-2025) & (US$ Million)
Table 123. Europe Pathological Examination Revenue by Country (2020-2025) & (US$ Million)
Table 124. Europe Pathological Examination Revenue by Country (2026-2031) & (US$ Million)
Table 125. Europe Pathological Examination Revenue by Type (2020-2025) & (US$ Million)
Table 126. Europe Pathological Examination Revenue by Application (2020-2025) & (US$ Million)
Table 127. Latin America Pathological Examination Revenue by Country (2020-2025) & (US$ Million)
Table 128. Latin America Pathological Examination Revenue by Country (2026-2031) & (US$ Million)
Table 129. Latin America Pathological Examination Revenue by Type (2020-2025) & (US$ Million)
Table 130. Latin America Pathological Examination Revenue by Application (2020-2025) & (US$ Million)
Table 131. Middle East and Africa Pathological Examination Revenue by Country (2020-2025) & (US$ Million)
Table 132. Middle East and Africa Pathological Examination Revenue by Country (2026-2031) & (US$ Million)
Table 133. Middle East and Africa Pathological Examination Revenue by Type (2020-2025) & (US$ Million)
Table 134. Middle East and Africa Pathological Examination Revenue by Application (2020-2025) & (US$ Million)
Table 135. Pathological Examination Key Raw Materials, Industry Status and Trend
Table 136. Pathological Examination Key Raw Materials and Upstream Suppliers
Table 137. Pathological Examination Clients Status and Trend
Table 138. Pathological Examination Typical Clients
Table 139. Pathological Examination Distributors
Table 140. Pathological Examination Market Trends
Table 141. Pathological Examination Market Drivers
Table 142. Pathological Examination Market Challenges
Table 143. Pathological Examination Market Restraints
Table 144. Research Programs/Design for This Report
Table 145. Key Data Information from Secondary Sources
Table 146. Key Data Information from Primary Sources
List of Figures
Figure 1. Pathological Examination Product Picture
Figure 2. Global Pathological Examination Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
Figure 3. Global Pathological Examination Revenue Market Share by Type in 2024 & 2031
Figure 4. Histopathology Product Picture
Figure 5. Cytopathology Product Picture
Figure 6. Immunohistochemical Pathology Product Picture
Figure 7. Molecular Pathology Product Picture
Figure 8. Global Pathological Examination Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
Figure 9. Global Pathological Examination Revenue Market Share by Application in 2024 & 2031
Figure 10. Hospital
Figure 11. Medical Laboratory
Figure 12. Pathological Examination Report Years Considered
Figure 13. Global Pathological Examination Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 14. Global Pathological Examination Market Size (2020-2031) & (US$ Million)
Figure 15. Global Pathological Examination Market Size Market Share by Region: 2024 Versus 2031
Figure 16. Global Pathological Examination Revenue Market Share by Region (2020-2031)
Figure 17. Global Pathological Examination Revenue Market Share Forecast by Type (2020-2031)
Figure 18. Global Pathological Examination Revenue Market Share Forecast by Application (2020-2031)
Figure 19. Histopathology of Pathological Examination Revenue Market Share by Application, 2024 VS 2031
Figure 20. Cytopathology of Pathological Examination Revenue Market Share by Application, 2024 VS 2031
Figure 21. Immunohistochemical Pathology of Pathological Examination Revenue Market Share by Application, 2024 VS 2031
Figure 22. Molecular Pathology of Pathological Examination Revenue Market Share by Application, 2024 VS 2031
Figure 23. Pathological Examination Revenue Share by Company (2024)
Figure 24. Pathological Examination Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 25. Histopathology Revenue Proportion by Company in 2024
Figure 26. Cytopathology Revenue Proportion by Company in 2024
Figure 27. Immunohistochemical Pathology Revenue Proportion by Company in 2024
Figure 28. Molecular Pathology Revenue Proportion by Company in 2024
Figure 29. North America Pathological Examination Revenue 2020-2031 (US$ Million)
Figure 30. North America Pathological Examination Revenue Market Share by Type (2020-2025)
Figure 31. North America Pathological Examination Revenue Market Share by Application (2020-2025)
Figure 32. Asia-Pacific Pathological Examination Revenue 2020-2031 (US$ Million)
Figure 33. Asia-Pacific Pathological Examination Revenue Market Share by Region (2020-2031)
Figure 34. Asia-Pacific Pathological Examination Revenue Market Share by Type (2020-2025)
Figure 35. Asia-Pacific Pathological Examination Revenue Market Share by Application (2020-2025)
Figure 36. Europe Pathological Examination Revenue Growth Rate 2020-2031 (US$ Million)
Figure 37. Europe Pathological Examination Revenue Market Share by Country (2020-2031)
Figure 38. Europe Pathological Examination Revenue Market Share by Type (2020-2025)
Figure 39. Europe Pathological Examination Revenue Market Share by Application (2020-2025)
Figure 40. Latin America Pathological Examination Revenue Growth Rate 2020-2031 (US$ Million)
Figure 41. Latin America Pathological Examination Revenue Market Share by Country (2020-2031)
Figure 42. Latin America Pathological Examination Revenue Market Share by Type (2020-2025)
Figure 43. Latin America Pathological Examination Revenue Market Share by Application (2020-2025)
Figure 44. Middle East and Africa Pathological Examination Revenue Growth Rate 2020-2031 (US$ Million)
Figure 45. Middle East and Africa Pathological Examination Revenue Market Share by Country (2020-2031)
Figure 46. Middle East and Africa Pathological Examination Revenue Market Share by Type (2020-2025)
Figure 47. Middle East and Africa Pathological Examination Revenue Market Share by Application (2020-2025)
Figure 48. Pathological Examination Supply Chain (Upstream and Downstream Market)
Figure 49. Global Production Market Share of Pathological Examination Raw Materials by Region in 2024
Figure 50. Pathological Examination Distribution Channels
Figure 51. Global Pathological Examination Percentage 2020-2031: Indirect Sales VS Direct Sales
Figure 52. Global Pathological Examination Percentage 2020-2031: Online Sales VS Offline Sales
Figure 53. Bottom-up and Top-down Approaches for This Report
Figure 54. Data Triangulation
Figure 55. Key Executives Interviewed